-+ 0.00%
-+ 0.00%
-+ 0.00%

MOLECULIN BIOTECH INC - PHASE 3 MIRACLE TRIAL OF ANNAMYCIN INTERIM DATA EXPECTED IN SECOND HALF OF 2025

Reuters·05/06/2025 13:00:02

Please log in to view news